Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
3
self-reported band not used
Founded
2020
6 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Educational
self-reported
Description
The Infectious Diseases Translational Research Programme (ID TRP) consists of basic scientists and clinician scientists for seamless translation of research which is a vibrant research environment at the NUS Yong Loo Lin School of Medicine with world-class facilities (BSL3 & ABSL3) and research support. Our ID programme aims to provide a holistic, patient-centric approach to infectious diseases that are relevant to Singapore and the region. ID TRP has strong expertise in bacterial antibiotic multi-drug resistance and emerging viruses, covering epidemiology, molecular mechanisms, animal models and therapeutic and prophylactic interventions. Other areas including phage biology, penumococcal infections and microbiome are also being actively developed under the programme.
Our goal is to position ID TRP as the first choice for students, research fellows and academics by providing a nurturing and cutting-edge research environment. We plan to strengthen peaks of excellence in deep pathogen-specific knowledge and expertise, particularly in molecular genetics and animal modelling.
Our main research areas are:
i) Pathogen evolution & transmission: To identify key factors and mechanisms that drive pathogen evolution and transmission at the genetic and molecular level. Includes phylogenetic studies and population genetics.
ii) Host-microbe interactions: To understand at the cellular and molecular level how pathogens interact with their hosts, and how the host responds to infection. The identification of molecular determinants of pathogens’ fitness and virulence guides the rational design of novel treatment options.
iii) Vaccine & therapeutics: To develop novel therapeutic and vaccine approaches including pathogen-specific approaches as well as development of versatile platforms. Leverages on strong expertise in primary organoid cultures and small animal models.
Specialties
All 3 specialties
- Pathogen evolution & transmission
- Host-microbe interactions
- Vaccines & Therapeutics
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG5 Science Drive 2; MD4, Level 2; Singapore, 117545Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
How many people work at NUS Medicine Infectious Diseases TRP?
3 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does NUS Medicine Infectious Diseases TRP have offices?
One address on record, Singapore only. Primary: 5 Science Drive 2, MD4, Level 2, Singapore 117545.
Has NUS Medicine Infectious Diseases TRP raised funding?
None linked to this brand.
What does NUS Medicine Infectious Diseases TRP list as its specialties?
Three tags on the brand's own list, among them Pathogen evolution & transmission, Host-microbe interactions and Vaccines & Therapeutics.
Which companies are listed alongside NUS Medicine Infectious Diseases TRP?
Six peer profiles on record: NUS Microbiology and Immunology and NUS Medicine Digital Advanced Technology Accelerator.